NASDAQ · Medical - Care Facilities

JYNT (JYNT) Stock

$8.60 +2.95% NASDAQ: JYNT Healthcare

Valuation

MetricValue
Price$8.60
Market Cap$122.55M
P/E Ratio45.89
P/B Ratio8.29
P/S Ratio2.20
EPS (TTM)$0.19
52-Week High$13.00
52-Week Low$7.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE20.00%
ROA4.92%
ROCE-6.67%
Gross Margin-1.82%
Operating Margin-1.82%
Net Margin5.72%
Debt/Equity0.13
Current Ratio1.58

Annual Financials (USD)

Metric20212022202320242025
Revenue$80.0M$101.0M$47.0M$52.0M$55.0M
Operating Profit$6.0M$1.0M$0$-2.0M$-1.0M
Net Profit$8.0M$1.0M$-10.0M$-6.0M$3.0M
EPS$0.44$0.04$-0.66$-0.39$0.19
Op Margin7.7%0.8%0.7%-3.6%-1.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$87.0M$93.0M$87.0M$83.0M$61.0M
Total Liabilities$57.0M$61.0M$62.0M$62.0M$46.0M
Cash$20.0M$10.0M$18.0M$25.0M$24.0M
Borrowings$24.0M$26.0M$3.0M$1.0M$2.0M

Latest News

The Joint Chiropractic Expands to 44th State with Opening of Rhode Island Clinic PR Newswire · Jul 1, 2026 The Joint Corp. Announces Milind Pant Elected as Director GlobeNewswire · May 21, 2026 Joint Q1 Earnings Call Highlights MarketBeat · May 8, 2026 The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates Zacks · May 8, 2026 The Joint Corp. Q1 2026 Earnings Call Summary Moby · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$14.0M$8.0M$15.0M$9.0M$2.0M
Investing Cash Flow$-20.0M$-24.0M$-11.0M$-2.0M$5.0M
Financing Cash Flow$1.0M$0$0$0$-11.0M
Net Cash Flow$-1.0M$-9.0M$9.0M$7.0M$-2.0M
Free Cash Flow$7.0M$2.0M$10.0M$8.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA102.31
FCF Yield2.13%
Quick Ratio1.61
Interest Coverage—
Return 1Y-21.83%
Return 3Y-32.15%
Return 5Y-89.44%

Ownership

Insiders Held16.10%
Institutions Held73.65%
Institutions Float Held87.78%
Institutional HolderSharesReport Date
Bandera Partners LLC3,937,2962026-03-31
Skylands Capital, LLC893,1952026-03-31
Blackrock Inc.754,5212026-03-31
Vanguard Capital Management LLC595,6072026-03-31
JCP Investment Management, LLC593,9062026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APYX $4.07 -1.21% -17.90 $171.39M 0.00%
BTMDbiote Corp. $2.36 +3.51% 4.58 $104.09M 0.00%
CCLD $2.23 +0.45% 22.80 $94.76M 0.00%
CGTX $0.89 +0.21% -3.94 $79.79M 0.00%
DCGO $0.65 +2.91% -0.33 $64.18M 0.00%

About JYNT

JYNT is led by CEO Sanjiv Razdan, employs 443 people, headquartered in US, publicly traded since 2014.

JYNT stock trades at $8.60 with a market capitalization of $122.55M. The stock is valued at a price-to-earnings (P/E) ratio of 45.89, price-to-book of 8.29, price-to-sales of 2.20. Over the past 52 weeks the stock has ranged between $7.50 and $13.00, and currently trades 33.8% below its 52-week high.

On profitability, JYNT generates a return on equity (ROE) of 20.00%, above the typical market average, return on capital employed of -6.67%, an operating margin of -1.82%, a net profit margin of 5.72%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides